- NewLimit co-founded by Brian Armstrong
- The funds are used to advance the mission of extending human life
Startup NewLimit, which was founded about 1.5 years ago, announced about attraction of $40 million of investments within a round of financing of series A. Investors were: Dimension, Kleiner Perkins, Founders Fund, as well as several private investors.
NewLimit is a San Francisco-based company with just 17 people. The main goal of the organization is to increase the number of healthy years of life for each person through “epigenetic reprogramming of cells.” This is what new capital will be spent on.
In total, the company has already raised $150 million. The lion’s share, namely $110 million, was funded by Coinbase CEO Brian Armstrong and vendor Blake Byers, who has a Ph.D. in bioengineering. In an interview, they talked about NewLimit’s future plans.
“The idea is that one day, if we succeed, we can make older people’s immune systems look younger and more functional.‘ Blake stated.
Armstrong was also asked that billionaires keep trying to extend life because they can’t take their billions together. Here is what he replied:
“My opinion is that if you’ve made money from software, then it’s pretty smart to reinvest the money back into society to improve people’s lives. One of the very important things is biotechnological research. In my opinion, they lack funding. If you look at the main diseases that kill people – heart disease, cancer, diabetes and dementia – they are often associated with aging. These diseases mostly affect non-young people. Therefore, I believe that we should try to solve the big and difficult problems in the world.”